ADIAL PHARMACEUTICALS, INC. (ADIL)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch ADIL
Latest sale
200,000
Oct 4 · Unusual
Form 4 sales
4
On record
Form 144 notices
0
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 salePlan not stated
    Dec 12 2019

    Sold 150,000 shares at $1.00 ($150k)

    Johnson Bankole A., Chief Medical Officer

    Sold 17.7% of holdings ($848k position)698,336 shares leftFirst sale on recordFiling

  2. 2 Form 4 saleUnusual
    Aug 20 +252 days

    Sold 350,000 shares at $1.21 ($424k)

    Johnson Bankole A., Chief Medical Officer

    Sold 99.7% of holdings ($425k position)1,055 shares leftFiling

  3. 3 Form 4 salePlan not stated
    Apr 6 +229 days

    Sold 150,000 shares at $2.50 ($375k)

    Johnson Bankole A., Chief Medical Officer

    Sold 21.5% of holdings ($1.7M position)548,336 shares leftFiling

  4. 4 Form 4 saleUnusual
    Oct 4 +181 days

    Sold 200,000 shares

    Johnson Bankole A., Chief Medical Officer

    Sold 57.4% of holdings148,246 shares left1.3x usual sizeFiling

Every transaction

Loading transactions…

Sales, notices and lockups (4)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for ADIL
Source
Oct 4, 2021Johnson Bankole A.Chief Medical OfficerForm 4 sale200,00057.4%UnusualSEC
Apr 6, 2021Johnson Bankole A.Chief Medical OfficerForm 4 sale150,000$375k21.5%Plan not statedSEC
Aug 20, 2020Johnson Bankole A.Chief Medical OfficerForm 4 sale350,000$424k99.7%UnusualSEC
Dec 12, 2019Johnson Bankole A.Chief Medical OfficerForm 4 sale150,000$150k17.7%Plan not statedSEC